Results
|
1.
|
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. MedStar authors:
Year: 2022
Citation: - European Heart Journal. 43(4):280-299, 2022 01 31.
Institution: - MedStar Heart & Vascular Institutena
Medline publication type:
All authors: - Armenian S, Barac A, Blaes A, Cardinale D, Carver J, Curigliano G, Dent S, Fradley MG, Ganatra S, Herrmann J, Ky B, Lang NN, Lenihan D, Liu JE, Lopez-Fernandez T, Lyon AR, Minotti G, Mitchell JD, Neilan TG, Nohria A, O'Quinn R, Porter C, Pusic I, Reynolds KL, Ruddy KJ, Thavendiranathan P, Valent P
|
|
2.
|
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. MedStar authors:
Year: 2020
Citation: - Annals of Oncology. 31(2):171-190, 2020 02.
Institution: - MedStar Heart & Vascular Institutena
Medline publication type:
All authors: - Armenian S, Barac A, Blaes A, Calabro MG, Cardinale D, Carver J, Cipolla CM, Curigliano G, de Azambuja E, DeCara J, Dent S, ESMO Guidelines Committee. Electronic address: [email protected], Fradley M, Ganatra S, Harrison E, Herrmann J, Iakobishvili Z, Jordan K, Krone R, Ky B, Lancellotti P, Lenihan D, Lyon AR, Mitchell J, Moslehi J, Orecchia R, Patel A, Porter C, Witteles R, Zamorano JL
|
|
3.
|
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. [] MedStar authors:
Year: 2014
Citation: - European heart journal cardiovascular Imaging. 15(10):1063-93, 2014 Oct.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Agler DA, Badano LP, Banchs J, Barac A, Cardinale D, Carver J, Cerqueira M, DeCara JM, Edvardsen T, Ewer MS, Flamm SD, Force T, Galderisi M, Ganame J, Griffin BP, Jerusalem G, Ky B, Lancellotti P, Liu JE, Magalhaes A, Marwick T, Plana JC, Sanchez LY, Scherrer-Crosbie M, Sebag IA, Sicari R, Villarraga HR
|
|
4.
|
Trastuzumab-Induced Cardiomyopathy. [Review] MedStar authors:
Year: 2019
Citation: - Cardiology Clinics. 37(4):407-418, 2019 Nov.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Barac A, Barish R, Gates E
|
|
5.
|
Frequency of Takotsubo Cardiomyopathy in Adult Patients Receiving Chemotherapy (from a 5-Year Nationwide Inpatient Study). MedStar authors:
Year: 2019
Citation: - American Journal of Cardiology. 123(4):667-673, 2019 02 15.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Abbas SA, Barac A, Desai R, Durairaj A, Fong HK, Goyal H, Hung O, Kumar G, Sachdeva R, Yusuf SW
|
|
6.
|
Advances in Multimodality Imaging in Cardio-Oncology: JACC State-of-the-Art Review. [Review] MedStar authors:
Year: 2022
Citation: - Journal of the American College of Cardiology. 80(16):1560-1578, 2022 Oct 18.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - ACC Cardio-Oncology and the ACC Imaging Councils, Ayoub C, Baldassarre LA, Barac A, DeCara JM, Dent S, Deswal A, Ganatra S, Ghosh AK, Henry M, Khemka A, Leja M, Liu JE, Lopez-Mattei J, Rudski L, Scherrer-Crosbie M, Villarraga HR, Wong TC, Yang EH, Zaha VG
|
|
7.
|
Cardiovascular Disease After Aromatase Inhibitor Use. MedStar authors:
Year: 2016
Citation: - JAMA Oncology. 2(12):1590-1597, 2016 Dec 01
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Amundsen B, Avila C, Barac A, Chlebowski RT, Chung J, Haque R, Schottinger JE, Shi J, Xu X
|
|
8.
|
|
|
9.
|
|
|
10.
|
Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis. MedStar authors:
- Barac, Ana
- Forrestal, Brian J
Year: 2020
Citation: - Journal of the American College of Cardiology. 75(5):467-478, 2020 02 11.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Alvi RM, Awadalla M, Bakar RB, Banerji D, Barac A, Chen CL, Cohen JV, Devereux RB, Ederhy S, Forrestal BJ, Fradley MG, Ganatra S, Groarke JD, Gupta D, Hassan MZO, Heinzerling LM, Hung J, Jones-O'Connor M, Kirchberger MC, Lawrence DP, Liu S, Lyon AR, Mahmood SS, Mahmoudi M, Mandawat A, Mercaldo ND, Mulligan CP, Murphy SP, Neilan TG, Nohria A, Picard MH, Reynolds KL, Rizvi MA, Rokicki A, Sahni G, Shah SP, Sullivan RJ, Thavendiranathan P, Thuny F, Tocchetti CG, Zhang L, Zlotoff DA
|
|
11.
|
Cardiovascular toxicity after antiangiogenic therapy in persons older than 65 years with advanced renal cell carcinoma. MedStar authors:
Year: 2016
Citation: - Cancer. 122(1):124-30, 2016 Jan 1.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Atkins MB, Barac A, Freedman AN, Fu AZ, Jang S, Minasian L, Potosky AL, Tsai HT, Zheng C
|
|
12.
|
|
|
13.
|
Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Herbolsheimer, Pia M
- Lynce, Filipa
- Mete, Mihriye
- Nunes, Raquel
- Shara, Nawar M
- Swain, Sandra M
- Wray, Lynette
Year: 2016
Citation: - Breast Cancer Research & Treatment. 155(2):285-93, 2016 Jan.
Institution:
- MedStar Health Research Institute
- MedStar Health Research Institute
- MedStar Health Research Institute
- MedStar Washington Hospital Center
- MedStar Washington Hospital Center
- Washington Cancer Institute
- Washington Cancer Institute
- Washington Cancer Institute A
- Washington Cancer Instituteia
Department:
- MedStar Heart Institute
- MedStar Heart Institute
Medline publication type:
All authors: - Asch FM, Barac A, Herbolsheimer P, Isaacs C, Lynce F, Mete M, Nardacci MP, Nunes RA, Peshkin BN, Shara NM, Smith KL, Swain SM, Warren R, Wray L
|
|
14.
|
SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Lynce, Filipa
- Swain, Sandra M
Year: 2017
Citation: - Oncologist. 22(5):518-525, 2017 May
Institution:
- MedStar Heart & Vascular Institute
- Washington Cancer Institute
Medline publication type:
All authors: - Asch FM, Barac A, Dang C, Isaacs C, Lynce F, Smith KL, Swain SM, Tan MT
|
|
15.
|
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Cunningham, A
- Gallagher, Christopher
- Hofmeyer, Mark
- Srichai, M B
- Swain, Sandra M
Year: 2019
Citation: - Breast Cancer Research & Treatment. 175(3):595-603, 2019 Jun.
Institution:
- MedStar Health
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
- Washington Cancer Institute
Department: - Associate Dean for Research Development
Medline publication type:
All authors: - Asch FM, Barac A, Cunningham A, Dang C, Gallagher C, Geng X, Herbolsheimer P, Hofmeyer M, Isaacs C, Lynce F, Nunes R, Pohlmann PR, Shajahan-Haq A, Smith KL, Srichai MB, Swain SM, Tan MT, Timothee P, Warren R, Yu AF
|